Ortho Clinical Diagnostics EPS beats by $0.02, beats on revenue

• Ortho Clinical Diagnostics (NASDAQ:OCDX): Q2 Non-GAAP EPS of $0.16 beats by $0.02; GAAP EPS of -$0.09 misses by $0.09.
• Revenue of $492.5M (+26.1% Y/Y) beats by $19.11M.
• Company raised 2021 guidance to 10% to 12% Core revenue growth in constant currency and adj. EBITDA growth to 15% to 17%; Core Revenue is seen at $1.95 - $1.98B; Adjusted Diluted EPS seen at $0.67 - $0.72.
• Press Release